Skip to main content
. 2023 Jan 10;14(1):2157159. doi: 10.1080/20008066.2022.2157159

Table 6.

Supplementary analysis (matched data) of treatment outcomes in different treatment groups: Secondary outcomes.

    Available data     Intent to treat data (n = 16)      
    Tbaseline Tpost-treatment     Tpost-treatment      
Measure Group N M(SD) N M(SD) da p M(SD) da p ANOVAb Factor p
MSI-BPD DBT-PTSD 16 6.90 (1.85) 6 4.17 (1.60) 1.79 .007 5.78 (2.22) 0.63 .023 F(1,30) = 9.211 Time .005
  TAU 16 6.88 (1.15) 10 5.00 (2.62) 0.63 .079 5.81 (2.40) 0.47 .080 F(1,30) = 0.0001 Group .995
  dc       0.36   .497 0.015   .966 F(1,30) = 0.008 Gr. x ti. .931
PHQ-9 DBT-PTSD 16 17.7 (4.92) 6 11.7 (3.56) 1.47 .015 14.9 (4.94) 0.59 .032 F(1,30) = 16.38 Time <.001
  TAU 16 18.1 (4.36) 11 13.5 (4.72) 1.21 .002 13.8 (4.31) 0.83 .005 F(1,30) = 0.051 Group .823
  dc       0.41   .432 0.23   .522 F(1,30) = 0.726 Gr. x ti. .401
GAD-7 DBT-PTSD 16 14.3 (4.44) 6 9.33 (4.50) 0.79 .112 12.9 (5.23) 0.42 .112 F(1,30) = 7.298 Time .011
  TAU 16 14.1 (3.94) 11 11.4 (3.67) 0.67 .049 12.0 (3.88) 0.53 .052 F(1,30) = 0.233 Group .633
  dc       0.51   .329 0.19   .595 F(1,30) = 0.158 Gr. x ti. .633
ERQ Reappraisal DBT-PTSD 16 22.9 (7.04) 6 24.7 (7.00) 0.16 .714 23.2 (6.92) 0.10 .690 F(1,30) = 2.308 Time .139
  TAU 16 21.7 (8.36) 10 24.5 (8.00) 0.48 .161 24.1 (7.50) 0.37 .157 F(1,30) = 0.004 Group .950
  dc       0.02   .967 0.12   .734 F(1,30) = 1.359 Gr. x ti. .253
ERQ Suppression DBT-PTSD 16 17.3 (6.19) 6 15.7 (5.57) 0.61 .199 16.4 (5.12) 0.35 .184 F(1,30) = 0.132 Time .719
  TAU 16 18.1 (6.56) 10 18.1 (4.28) 0.08 .798 18.4 (5.01) 0.07 .791 F(1,30) = 0.557 Group .461
  dc       0.12   .742 0.41   .259 F(1,30) = 0.719 Gr. x ti. .403
WHODAS DBT-PTSD 16 23.9 (9.18) 6 21.1 (10.7) 1.11 .042 22.4 (9.01) 0.52 .055 F(1,30) = 9.767 Time .004
  TAU 16 23.6 (6.83) 11 20.3 (8.23) 0.80 .024 20.4 (6.97) 0.61 .028 F(1,30) = 0.181 Group .674
  dc       0.08 0.880   0.26   .474 F(1,30) = 1.384 Gr. x ti. .249

Note: DBT-PTSD = Dialectical Behavioural Therapy – Posttraumatic Stress Disorder, TAU = Treatment as usual, MSI-BPD = McLean Screening Instrument for Borderline Personality Disorder, PHQ-9 = Patient Health Questionnaire-9, GAD-7 = Brief Measure for assessing General Anxiety Disorder, ERQ = Emotion Regulation Questionnaire, WHODAS = WHO Disability Assessment Schedule.

a

Cohen’s d was computed using the pooled standard deviation of scores at admission (t1) and discharge (t2).

b

Repeated measures analysis of variance with intent to treat data.

c

Cohen’s d was computed using the pooled standard deviation of scores at discharge (t2) from the DBT-PTSD and TAU groups.